首页 | 本学科首页   官方微博 | 高级检索  
检索        


Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemia
Authors:Dana Wetzel  Beatrice U Mueller  Behrouz Mansouri Taleghani  Gabriela M Baerlocher  Katja Seipel  Kurt Leibundgut  Thomas Pabst
Institution:1. Department of Medical Oncology, University Hospital and University of Berne, Berne, Switzerland;2. Department of Clinical Research, University Hospital and University of Berne, Berne, Switzerland;3. Department of Haematology, University Hospital and University of Berne, Berne, Switzerland;4. Department of Paediatric Haemato‐Oncology, University Hospital and University of Berne, Berne, Switzerland
Abstract:Autologous stem cell transplantation (ASCT) is applied to consolidate first remission in patients with acute myeloid leukaemia (AML). However, outcome after ASCT widely varies among AML patients. We analyzed the prognostic significance of haematological recovery for neutrophils absolute neutrophil count (ANC) >1·0 × 109/l] and platelets (platelet count >20·0 × 109/l), stratifying at day 20 after ASCT in 88 consecutive and homogeneously treated AML patients in first remission. We observed that patients with delayed recovery had better overall survival (OS; ANC: P < 0·0001 and platelets: P = 0·0062) and time to progression (TTP; ANC: P = 0·0003 and platelets: P = 0·0125). Delayed recovery was an independent marker for better OS and TTP in a multivariate analysis including age, gender, number of transfused CD34+ cells, cytogenetics, FLT3‐internal tandem duplication and NPM1 mutation. Our results suggest that delayed neutrophil and platelet recovery is associated with longer OS and TTP in AML patients consolidated with ASCT in first remission.
Keywords:autologous transplant  acute myeloid leukaemia  recovery  prognosis  stem cell
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号